Real Brands Inc. announced that it has added Richard J. Goldberg, MD, MS, to its Board of Directors, and The Company has entered into a consulting agreement with Dr. Goldberg for guidance and expertise in Real Brand's new Psychedelics research division that was launched in 2023. Dr. Goldberg has been appointed to the highest levels in Psychiatry at premier academic and healthcare institutions, has served on the editorial boards and review committees for the top peer-reviewed Psychiatry medical journals, served on dozens of advisory boards and committees, has founded and led successful healthcare corporations, and has had scores of papers published in peer-reviewed medical journals. Dr. Goldberg's career highlights include: Brown University, Professor, Dept.

of Psychiatry and Human Behavior, Dartmouth Medical School, Adjunct Professor, Dept. of Psychiatry, Yale University, Director, Program of Behavioral Medicine for Interns, American Association of General Hospital Psychiatrists, President, American Association of Geriatric Psychiatry, Chairman, Fellowship Committee, American Board of Psychiatry and Neurology, Examiner, Brown University, Editor-in-Chief, Geriatric Psychopharmacology Update, Psychiatry Foundation of RI, Inc, President & Founder, The Providence Center for Mental Health Services, Board of Directors and Chair of Long-Range Planning and Patient Care, State of Rhode Island, Governors Committee on Service and Populations, Statewide Behavioral Health Planning, Memoir Health, Chief Strategy Officer, Lumeo Health, Founder and CEO, Lifespan Healthcare Corporation, Senior Vice President, Psychiatry & Behavioral Health Service Line, Lifespan Healthcare Corporation, Senior Vice President, Physician Network Development, National Quality Forum, Mental Health Steering Committee, Psychiatrist-in-Chief at Rhode Island Hospital, Women & Infants Hospital, and Miriam Hospital.